Spironolactone and Repatha drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among people who take Spironolactone (spironolactone) and Repatha (evolocumab). Common drug interactions include muscle spasms among females and dyspnoea among males.
The phase IV clinical study analyzes what interactions people have when they take Spironolactone and Repatha. It is created by eHealthMe based on reports of 316 people who take the same drugs from the FDA, and is updated regularly.
What is Spironolactone?
Spironolactone has active ingredients of spironolactone. It is often used in acne. eHealthMe is studying from 122,947 Spironolactone users. Check the latest studies of Spironolactone.
What is Repatha?
Repatha has active ingredients of evolocumab. It is often used in high blood cholesterol. eHealthMe is studying from 156,258 Repatha users. Check the latest studies of Repatha.
eHealthMe: drug outcomes in the real world
eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.
316 people who take Spironolactone and Repatha together, and have interactions are studied.
What are the common drug interactions of Spironolactone and Repatha, by gender? *
What are the common drug interactions of Spironolactone and Repatha, by age (0-1 to 60+)? *
What are the existing conditions these people have? *
* Approximation only. Some reports may have incomplete information.
Do you take Spironolactone and Repatha?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
- Spironolactone (122,947 reports)
- Repatha (156,258 reports)
Browse all drug interactions of Spironolactone and Repatha:
a b c d e f g h i j k l m n o p q r s t u v w x y zSub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Spironolactone:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Repatha:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Spironolactone and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Repatha and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zHow the study uses the data?
The study uses data from the FDA. It is based on spironolactone and evolocumab (the active ingredients of Spironolactone and Repatha, respectively), and Spironolactone and Repatha (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Lovenox and Pulmonary Embolism for Women aged 20-29 - now
- Could Singulair cause Gastroenteritis Norovirus? - a second ago
- Lovenox and Pulmonary Embolus for Women aged 20-29 - a second ago
- Could Belsomra cause White Blood Cell Count Decreased? - a second ago
- Could Fish Oil cause Sleep Apnea Syndrome? - 2 seconds ago
- Drug interactions of Paxil Cr and Lexapro - 3 seconds ago
- Could Chondroitin cause Pain In Extremity? - 3 seconds ago
- Could Vesicare cause Dry Skin? - 5 seconds ago
- Could Darzalex cause Sepsis? - 6 seconds ago
- Could Oxaliplatin cause Stroke? - 6 seconds ago